MAPKAPK5 and posterior cortical atrophy: Finally, we observed that pharmacologic inhibition of MK5 leads to a drastic reduction of motility in a panel of androgen-dependent or -independent PCa cell lines, even at a low dose (1–5 μM concentration) [7].